Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children

BACKGROUND: Grass pollen-induced rhinoconjunctivitis is a common allergic respiratory disorder affecting over 20% of the UK population in terms of quality of life and sleep, work, and school patterns. The SQ-standardized grass allergy immunotherapy tablet (AIT) has been demonstrated as a disease-mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronaldson, Sarah, Taylor, Matthew, Bech, Peter G, Shenton, Ruth, Bufe, Albrecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011810/
https://www.ncbi.nlm.nih.gov/pubmed/24812522
http://dx.doi.org/10.2147/CEOR.S44079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011810/
https://www.ncbi.nlm.nih.gov/pubmed/24812522
http://dx.doi.org/10.2147/CEOR.S44079

Ejemplares similares